Starting With the Questions That Matter
When you are living with persistent mental-health symptoms, it is understandable to look for a different path. You may have tried medication, therapy, lifestyle changes, or several approaches at once. You may also have questions that do not fit neatly into a search bar.
At KetaMed Infusion Center, we offer ketamine treatment for mental health and pain with the understanding that no treatment decision should be rushed. Ketamine can be an important area of discussion for some people. It is not a simple answer, and it is not the right fit for everyone.
Ketamine has long been used in medical settings as an anesthetic. In mental-health care, ketamine is used differently, at lower and carefully considered doses. These psychiatric uses are off-label, meaning the FDA has not approved ketamine specifically for psychiatric conditions. That distinction matters. So does a thoughtful conversation about your history, current symptoms, medications, goals, and safety.
What Researchers Think Ketamine May Be Doing
Most traditional antidepressant medications primarily affect monoamine neurotransmitters, such as serotonin or norepinephrine. Ketamine appears to work through a different pathway. It interacts with the brain’s glutamate system, which is involved in communication between nerve cells, learning, and adaptation.
Researchers continue to study how this interaction may affect mood and thought patterns. One leading theory is that ketamine’s effects on glutamate signaling may support synaptic plasticity, the brain’s capacity to form and strengthen connections. Research on glutamatergic modulators describes this pathway as a meaningful area of investigation in depression care, while also making clear that the full clinical picture is more complex than any single mechanism (McIntyre et al., 2024).
That complexity is important. The brain is not a switchboard with one wire to repair. Mental-health symptoms can involve biology, relationships, trauma, sleep, stress, physical health, substance use, and many other parts of a person’s life.
For some patients, ketamine may create a period in which symptoms feel less fixed or less consuming. For others, the experience may be different. We do not present the proposed mechanism as a promise. We treat it as one part of an ongoing clinical conversation.
What the Current Evidence Can and Cannot Tell Us
The evidence base for ketamine and related treatments has grown, particularly in the study of treatment-resistant depression. An international review of ketamine and esketamine evidence found support for their role in carefully selected patients, while emphasizing the need for appropriate implementation, monitoring, and longer-term planning (McIntyre et al., 2021).
“Treatment-resistant” is often used casually, but it deserves care. It generally refers to symptoms that have not improved adequately after appropriate treatment attempts. Even then, the details matter. Consensus work on defining treatment-resistant depression reflects how much clinical context is needed to understand prior treatment adequacy, adherence, and outcomes (Sforzini et al., 2022).
There are still limits to what we know. Studies vary in dose, route of administration, patient selection, follow-up periods, and accompanying care. We also need more information about long-term maintenance, the best schedules for different individuals, and who is most likely to benefit.
A systematic review of maintenance ketamine research noted encouraging findings while also identifying gaps in longer-term efficacy and safety data (Smith-Apeldoorn et al., 2022). That is why we believe ongoing reassessment matters. A treatment plan should remain responsive to what is actually happening in your life.
A Treatment Experience Is More Than a Medication
Ketamine therapy is not just about receiving a medication. The setting, preparation, monitoring, follow-up, and broader care plan all matter.
We offer IV ketamine therapy, IM ketamine therapy, and ketamine troches. Each option has practical and clinical differences. Some patients arrive with a strong preference for one route. We listen carefully, but a recommendation should be grounded in the whole clinical picture, not preference alone. Our discussion of IM and IV delivery methods explains why route of administration is an individualized decision.
Ketamine can produce temporary changes in perception, awareness, or the sense of time. Some people describe the experience as inward or emotionally significant. Others find it unfamiliar. We prepare patients for what may occur, monitor them closely during in-office care, and make room for questions afterward.
This is also why we encourage patients to continue working with their existing mental-health providers when appropriate. Ketamine does not replace the value of therapy, psychiatric care, supportive relationships, sleep, movement, or practical stability. It may be one part of care. It should not be asked to carry the whole weight alone.
Why an Individual Evaluation Comes First
For many people, the most useful first step is not deciding on a treatment. It is building a complete clinical picture.
We review your symptoms, treatment history, medications, medical history, and current supports. We also discuss what you hope will change. Sometimes that conversation leads toward ketamine therapy. Sometimes it points toward additional evaluation, coordination with another clinician, stabilization, or a different approach.
Our initial ketamine evaluation is designed for that kind of careful discussion. We want to understand not only a diagnosis, but the texture of your daily life and what you have already carried.
Certain circumstances may require extra caution or make ketamine inappropriate at a given time. These can include some medical conditions, uncontrolled blood pressure concerns, substance-use considerations, or symptoms that need a different level of immediate support. A controlled medication requires responsible prescribing, clear boundaries, and attention to risks. Guidance on controlled-substance benefits and risks underscores the importance of individualized clinical judgment and monitoring (Preuss et al., 2019).
When Safety Needs to Come Before a Consultation
If you are having thoughts of suicide, feel unable to stay safe, or believe you may act on those thoughts, please seek immediate help. Call or text the 988 Suicide and Crisis Lifeline at 988, call 911, or go to the nearest emergency department.
Research has examined ketamine in acute suicidal ideation, including a randomized clinical trial in severe suicidal thoughts that found rapid improvement for some participants within a closely monitored care setting (Abbar et al., 2022). But an urgent safety crisis needs urgent support. It should not wait for an outpatient consultation.
For non-emergency questions about ongoing symptoms, our information on suicidal ideation care may help you begin a conversation about next steps.
Frequently Asked Questions
Does ketamine work the same way as a traditional antidepressant?
Not exactly. Traditional antidepressants often focus on serotonin, norepinephrine, or related systems. Ketamine appears to affect glutamate signaling and may influence brain plasticity. The exact reasons one person responds and another does not are still being studied.
Is ketamine therapy approved for mental-health conditions?
Ketamine itself is used off-label for psychiatric purposes. Off-label use is legal and common in medicine, but it requires informed discussion and individualized clinical judgment. SPRAVATO® is a separate FDA-approved prescription product containing esketamine, with its own indication and treatment requirements.
How do you decide between IV, IM, or troches?
We consider your health history, treatment goals, practical circumstances, response over time, and safety needs. You can also read more about ketamine troches at home, including why follow-up and clear instructions remain important.
What if I am unsure whether ketamine is right for me?
That uncertainty is a reasonable place to begin. You do not need to arrive with a decision. A consultation is an opportunity to ask questions, review your history, and understand whether ketamine therapy is appropriate to consider.
Key Takeaways
Ketamine therapy for mental health is an evolving area of care. Research offers real reasons for interest, especially for people whose symptoms have remained difficult despite previous treatment. It also leaves important questions unanswered.
We believe patients deserve both honesty and attention. We take time to understand the full arc of your care, explain what we know without overstating it, and make recommendations based on your individual circumstances. If you are in Salisbury or elsewhere on Delmarva and would like to talk through your options, reach out for a consultation.
This article is for educational purposes only. It is not medical advice and does not replace an individualized evaluation by a qualified clinician.
Works Cited
1. McIntyre RS, et al. Glutamatergic Modulators for Major Depression from Theory to Clinical Use. https://pubmed.ncbi.nlm.nih.gov/39150594/
2. McIntyre RS, et al. Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation. https://pubmed.ncbi.nlm.nih.gov/33726522/
3. Sforzini L, et al. A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials. https://pubmed.ncbi.nlm.nih.gov/34907394/
4. Smith-Apeldoorn SY, et al. Maintenance ketamine treatment for depression: a systematic review of efficacy, safety, and tolerability. https://pubmed.ncbi.nlm.nih.gov/36244360/
5. Preuss CV, et al. Prescription of Controlled Substances: Benefits and Risks. StatPearls. Updated 2019. https://pubmed.ncbi.nlm.nih.gov/30726003/
6. Abbar M, et al. Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial. https://pubmed.ncbi.nlm.nih.gov/35110300/
7. 988 Suicide and Crisis Lifeline. https://988lifeline.org/
Disclaimer
This article is for educational purposes only and is not a substitute for individualized evaluation, diagnosis, or treatment from a qualified healthcare professional.